ASML vs EDIT
ASML Holding NV ADR (ASML) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
ASML does not have a complete income-statement cache yet.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the ASML and EDIT stock pages for the full models.
Not investment advice.